Global Mouth Ulcers Treatment Market 2016: Corticosteroid, Antihistamine, Antimicrobial

Mouth ulcers are painful breaks and sores appearing in the mucous membrane of the oral cavity. Increasing use of chemicals in food and oral products such toothpaste, anxiety and stress, and the use of tobacco are some of the factors that may trigger recurrent mouth ulcers. The global Mouth ulcer treatment market has observed tremendous growth owing to the growing consciousness for dental and oral hygiene, globally. The presence of moisture and saliva in oral cavity often hinders the topical application of drugs. There is a rising demand for rapid healing and easy to use products.

Technical advancements in the field of dental care and the increasing use of pharmaceuticals for oral treatment fuel the market growth. The factors driving the global mouth ulcers treatment market are; higher prevalence of mouth ulcers, increasing disease and treatment awareness, rising adoption of pharmaceuticals as a treatment option and a significant rise in the count of geriatric population. However, presence of substitute traditional treatments and limited accessibility to pharmaceuticals in developing countries are likely to curtail the market growth.

Access Full Report: http://www.intenseresearch.com/market-analysis/world-mouth-ulcers-treatment-market-opportunities-and-forecasts.html

The global mouth ulcers treatment market is segmented on the basis of drug type, formulation, indication and geography. On the basis of drug type, the market is further segmented into Corticosteroid, Antihistamine, Antimicrobial, Analgesic and Anesthetic. According to formulation the market is segment into, Mouthwash, Ointment, Spray Gel and Lozenges. The market is also segmented on the basis of indication into Aphthous Stomatitis, Oral Lichen Planus and Others. Geographically, the market is segmented across four regions namely North America, Europe, Asia Pacific and LAMEA.

Product launch is a key strategy adopted by top industry players. For instance, recently Piramal Enterprises has launched QuikKool, a mouth ulcer gel. The companies profiled in the report include, GlaxoSmithKline plc, ECR Pharmaceuticals, Co., Inc, Pfizer, Inc., Bristol-Myers Squibb Company, Church & Dwight Co. Inc., Taro Pharmaceutical Industries Ltd., 3M Health Care Ltd., and Colgate-Palmolive Company

Request a Brochure of This Report, here: http://bit.ly/2cSTv0s

About Intense Research

Intense Research provides a range of marketing and business research solutions designed for our client’s specific needs based on our expert resources. The business scopes of Intense Research cover more than 30 industries includsing energy, new materials, transportation, daily consumer goods, chemicals, etc. We provide our clients with one-stop solution for all the research requirements.

Contact Us:

Joel John
3422 SW 15 Street, Suit #8138,
Deerfield Beach, Florida 33442,
United States
Tel: +1-386-310-3803
GMT Tel: +49-322 210 92714
USA/Canada Toll Free No. 1-855-465-4651
Email: sales@intenseresearch.com
Web: http://www.intenseresearch.com/

This release was published on openPR.